Cetera Investment Advisers
PHIO icon

Cetera Investment Advisers’s Phio Pharmaceuticals PHIO Stock Holding History

Cetera Investment Advisers’s Portfolio PHIO Stock Details PHIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$54.9K Buy
45,000
+2,500
+6% +$2.85K ﹤0.01% 4570
2025
Q4 		$44.6K Buy
42,500
+9,000
+27% +$14.4K ﹤0.01% 4521
2025
Q3 		$83.1K Buy
33,500
+1,000
+3% +$2.28K ﹤0.01% 4362
2025
Q2 		$76.4K Sell
32,500
-6,000
-16% -$12.1K ﹤0.01% 3924
2025
Q1 		$50K Buy
38,500
+25,500
+196% +$47.1K ﹤0.01% 3859
2024
Q4 		$23.4K Buy
+13,000
New +$35.3K ﹤0.01% 3699
2024
Q3 		– Sell
-3,935
Closed -$24.5K – 3870
2024
Q2 		$24.5K Buy
3,935
+555
+16% +$3.63K ﹤0.01% 3636
2024
Q1 		$20.7K Buy
3,380
+1,500
+80% +$10.3K ﹤0.01% 3628
2023
Q4 		$12.9K Buy
1,880
+695
+59% +$7.14K ﹤0.01% 2203
2023
Q3 		$16.1K Hold
1,185
– – ﹤0.01% 2165
2023
Q2 		$30.6K Buy
+1,185
New +$41.6K ﹤0.01% 2140
2023
Q1 		– Sell
-694
Closed -$27.9K – 2224
2022
Q4 		$27.9K Hold
694
– – ﹤0.01% 2056
2022
Q3 		$43K Hold
694
– – ﹤0.01% 1620
2022
Q2 		$53K Sell
694
-139
-17% -$13.1K ﹤0.01% 1765
2022
Q1 		$80K Buy
833
+463
+125% +$44.1K ﹤0.01% 1818
2021
Q4 		$40K Buy
370
+92
+33% +$14.6K ﹤0.01% 1833
2021
Q3 		$61K Buy
+278
New +$58.1K ﹤0.01% 1757

Other funds holding PHIO

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
SRL
Scientech Research LLC Jersey City, New Jersey $120M AUM 73.62% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Cetera Investment Advisers's PHIO Position: Q1 2026 in Review

Cetera Investment Advisers increased its Phio Pharmaceuticals (PHIO) stake by 5.9% in Q1 2026, buying an estimated $2.85K and bringing the position to 45,000 shares worth $54.9K. The position accounts for ﹤0.01% of the portfolio, ranked #4570.

Cetera Investment Advisers first reported a position in PHIO in Q3 2021 and has held it in 17 quarters since. The position peaked at $83.1K in Q3 2025. 24 funds tracked by Wall St. Rank hold PHIO as of Q1 2026.

  • Cetera Investment Advisers held 45,000 shares of Phio Pharmaceuticals worth $54.9K as of Q1 2026.
  • Cetera Investment Advisers bought 2,500 Phio Pharmaceuticals shares in Q1 2026, an estimated $2.85K.
  • Phio Pharmaceuticals made up ﹤0.01% of Cetera Investment Advisers's portfolio in Q1 2026, its #4570 holding.
  • Cetera Investment Advisers first reported a position in Phio Pharmaceuticals in Q3 2021 and has held it in 17 quarters since.
  • Cetera Investment Advisers's Phio Pharmaceuticals position peaked at $83.1K in Q3 2025.
  • 24 funds tracked by Wall St. Rank held Phio Pharmaceuticals as of Q1 2026.

Based on Cetera Investment Advisers's 13F filing for Q1 2026, filed 13 May 2026.